Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Anthera Pharmaceuticals Inc

+ Add to Watchlist

6TA1:GR

3.929 EUR 0.005 0.13%

As of 02:09:27 ET on 04/02/2015.

Snapshot for Anthera Pharmaceuticals Inc (6TA1)

Open: 3.928 Day's Range: 3.928 - 3.948 Volume: 0
Previous Close: 3.934 52wk Range: 1.203 - 5.734 1-Yr Rtn: +60.50%

Stock Chart for 6TA1

No chart data available.
  • 6TA1:GR 3.928
  • 1D
  • 1M
  • 1Y
3.934
Interactive 6TA1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 6TA1

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) -1.1650
Est. PEG Ratio -
Market Cap (M EUR) 112.22
Shares Outstanding (M) 28.56
30 Day Average Volume 2,072
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 6TA1

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 6TA1

Anthera Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing anti-inflammatory therapeutics for cardiovascular diseases, lupus and other serious diseases.

Paul F TruexPresident/CEO/FounderDebra OdinkSenior VP/CTO
Colin HislopSenior VP/Chief Medical OfcrKlara A Dickinson-EasonSenior VP/Chief Regulatory Ofcr
More Company Profile & Key Executives for 6TA1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil